Comparison of the effect of reversible and irreversible MAO inhibitors on renal nerve activity in the anesthetized rat
Cardiovascular effects of the irreversible MAO-A inhibitor clorgyline and reversible MAO-inhibitors, moclobemide and brofaromine, were compared in the anesthetized rat. Electrical activity of the sympathetic renal nerve was monitored as an index of central sympathetic output. A long lasting decrease in the recorded parameters: blood pressure (BP), renal nerve activity (RNA) and heart rate (HR) was produced by acute administration of clorgyline (2 mg/Kg, IP). Acute treatment with moclobemide (10 mg/Kg, IP) or brofaromine (10 mg/Kg, IP) caused only a transient decrease in RNA. Pretreatment with the α2 antagonist yohimbine, decreased significantly the inhibitory effect of clorgyline on all three parameters. The selective α2 antagonist CH-38083 blocked the sympathoinhibitory effect of brofaromine. These results indicate an α2 adrenoceptor involvement in the central sympathoinhibitory effect of MAO inhibitors, which may be manifested as a hypotensive effect, including orthostatic hypotension, in patients treated with irreversible selective MAO inhibitors.
KeywordsMonoamine Oxidase Antagonist Yohimbine Renal Nerve Activity Yohimbine Hydrochloride Sympathoinhibitory Effect
Unable to display preview. Download preview PDF.
- Da Prada M, Kettler R, Burkard WP, Haefely WE (1984) Moclobemide, an antidepressant with short-acting MAO-A inhibition: brain catecholamines and tyramine pressor effects in rats. In: Tipton KF, Dosiert P, Strolin-Benedetti M (eds) Monoamine oxidase and disease. Prospect for therapy with reversible inhibitors. Academic Press, London, pp 137–154.Google Scholar
- Finberg JPM, Youdim MBH (1988) Potentiation of tyramine pressor responses in conscious rats by reversible inhibitors of monoamine oxidase. J Neural Transm [Suppl] 26: 11–16.Google Scholar
- Gasic S, Korn A, Eichler HC, Oberhummer I, Zapotoczky HG (1983) Cardiocirculatory effects of moclobemide (RO 11-1163), a new reversible, short acting MAO-inhibitor with preferential type A inhibition, in healthy volunteers and depressive patients. Eur J Clin Pharmacol 25: 173–177.PubMedCrossRefGoogle Scholar
- Guyenet PG, Haselton JR, Sun MK (1989) Sympathoexcitatory neurons of the rostroventral medulla and the origin of the sympathetic vasomotor tone. In: Cirielo J, Caverson MM, Polosa C (eds) Progress in brain research, vol 91. Elsevier, p 105.Google Scholar
- Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17: 614–627.Google Scholar
- Neff NH, Goridis C (1972) Neuronal monoamine oxidase: specific enzyme types and their rate of formation. In: Costa E, Sandler M (eds) Monoamine oxidase and the monoamine oxidase inhibitor drugs—new vistas. Raven Press, New York, p 307.Google Scholar
- Neff NH, Yang HYT, Fuentes JA (1974) The use of selective monoamine metabolism in brain. In: Usdin E (eds) Neuropharmacology of monoamines and their regulatory enzymes. Raven Press, New York, p 49 (Adv Biochem Psychopharmacol, vol 12).Google Scholar